NCT06007950 Time-restricted Eating Study (TRES): Impacts on Anthropometric, Cardiometabolic and Cardiovascular Health
| NCT ID | NCT06007950 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universiti Teknologi Mara |
| Condition | Myocardial Infarction |
| Study Type | INTERVENTIONAL |
| Enrollment | 48 participants |
| Start Date | 2023-09-01 |
| Primary Completion | 2024-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 48 participants in total. It began in 2023-09-01 with a primary completion date of 2024-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn about the effects of time-restricted eating in patients with history of acute coronary syndrome. The main questions it aims to answer are: 1) Is 10-hr TRE safe and feasible for patients with ACS; 2)What are the impacts of 10-hr TRE on anthropometric measurements, cardiometabolic health and cardiovascular health compared to ad libitum eating in patients with ACS?. Participants will be asked to limit eating duration to 10 hours daily.
Eligibility Criteria
Inclusion Criteria: * Adult, 18- 65 years old. * Had history of acute coronary syndrome (ACS) * Clinically stable * Self-reported eating window of at least 12 h per day. Exclusion Criteria: * Severe obesity (body mass index ≥40 kg m-2). * Unstable weight in the past three months (gain or lose more than 4 kg of weight). * Unstable cardiovascular, renal, cardiac, liver, lung, adrenal, or nervous system disease that may compromise study validity. * Any medications or supplements known to change sleep, circadian rhythms, or metabolism. * Pregnant or lactating women. * Perform overnight shift work more than one day/week on average. * Regularly fasted for more than 15 hours/day or having completed twelve 24-hr fasts within the past three months). * Active use of tobacco or illicit drug or history of treatment for alcohol abuse. * Type I diabetes or diabetic, treated with insulin. * Use of anti-obesity drugs or other drugs affecting body weight. * Currently enrolled in weight loss or management programme, including surgical intervention. * Severe kidney failure (glomerular filtration rate (GFR) \<30 mL/min). * Eating disorder or current diagnosis of uncontrolled psychiatric illness, which may impair study involvement. * Malignancy undergoing active treatment. * Had gastrointestinal surgery or impaired nutrient absorption. * Travelled more than two time zones away two months prior to enrolling in the trial or will travel more than two time zones away during the study period. * Concurrent participation in other interventional studies
Contact & Investigator
Mazuin Kamarul Zaman, MMed Sc
PRINCIPAL INVESTIGATOR
Universiti Teknologi Mara
Frequently Asked Questions
Who can join the NCT06007950 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Myocardial Infarction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06007950 currently recruiting?
Yes, NCT06007950 is actively recruiting participants. Contact the research team at mazuin0233@uitm.edu.my for enrollment information.
Where is the NCT06007950 trial being conducted?
This trial is being conducted at Kuala Selangor, Malaysia.
Who is sponsoring the NCT06007950 clinical trial?
NCT06007950 is sponsored by Universiti Teknologi Mara. The principal investigator is Mazuin Kamarul Zaman, MMed Sc at Universiti Teknologi Mara. The trial plans to enroll 48 participants.